AMLX
Price
$11.96
Change
+$0.11 (+0.93%)
Updated
Sep 16 closing price
Capitalization
1.26B
50 days until earnings call
JAZZ
Price
$126.54
Change
+$1.32 (+1.05%)
Updated
Sep 16 closing price
Capitalization
7.6B
49 days until earnings call
Interact to see
Advertisement

AMLX vs JAZZ

Header iconAMLX vs JAZZ Comparison
Open Charts AMLX vs JAZZBanner chart's image
Amylyx Pharmaceuticals
Price$11.96
Change+$0.11 (+0.93%)
Volume$1.29M
Capitalization1.26B
Jazz Pharmaceuticals
Price$126.54
Change+$1.32 (+1.05%)
Volume$649.54K
Capitalization7.6B
AMLX vs JAZZ Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. JAZZ commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and JAZZ is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (AMLX: $11.96 vs. JAZZ: $126.54)
Brand notoriety: AMLX and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 86% vs. JAZZ: 88%
Market capitalization -- AMLX: $1.26B vs. JAZZ: $7.6B
AMLX [@Biotechnology] is valued at $1.26B. JAZZ’s [@Biotechnology] market capitalization is $7.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while JAZZ’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • JAZZ’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а +13.80% price change this week, while JAZZ (@Biotechnology) price change was -1.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.37%. For the same industry, the average monthly price growth was +6.95%, and the average quarterly price growth was +36.10%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

JAZZ is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($7.6B) has a higher market cap than AMLX($1.26B). JAZZ has higher P/E ratio than AMLX: JAZZ (15.38) vs AMLX (2.69). AMLX YTD gains are higher at: 216.402 vs. JAZZ (2.753). JAZZ has higher annual earnings (EBITDA): 372M vs. AMLX (-196.3M). JAZZ has more cash in the bank: 1.67B vs. AMLX (181M). AMLX has less debt than JAZZ: AMLX (5.96M) vs JAZZ (5.43B). JAZZ has higher revenues than AMLX: JAZZ (4.09B) vs AMLX (-249K).
AMLXJAZZAMLX / JAZZ
Capitalization1.26B7.6B17%
EBITDA-196.3M372M-53%
Gain YTD216.4022.7537,861%
P/E Ratio2.6915.3817%
Revenue-249K4.09B-0%
Total Cash181M1.67B11%
Total Debt5.96M5.43B0%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
72
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXJAZZ
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
64%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
61%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
50%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
56%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 9 days ago
59%
Declines
ODDS (%)
Bearish Trend 19 days ago
82%
Bearish Trend 2 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGWCX37.57N/A
N/A
Virtus Silvant Focused Growth C
AREWX26.23N/A
N/A
American Century Real Estate R
MNDFX8.76N/A
N/A
Manning & Napier Disciplined Value I
FNGZX18.56N/A
N/A
Franklin Intl Growth Adv
CSRSX67.72-0.28
-0.41%
Cohen & Steers Realty Shares L

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+0.93%
XOMAO - AMLX
68%
Closely correlated
-0.06%
XOMAP - AMLX
51%
Loosely correlated
N/A
LRMR - AMLX
46%
Loosely correlated
+1.01%
RGNX - AMLX
45%
Loosely correlated
+1.87%
OCUL - AMLX
44%
Loosely correlated
-0.84%
More